AI Spotlight on ELV
Company Description
Elevance Health Inc.operates as a health benefits company.It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives.
It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.The company was formerly known as Anthem, Inc.and changed its name to Elevance Health Inc.
in June 2022.Elevance Health Inc.was founded in 1944 and is headquartered in Indianapolis, Indiana.
Market Data
Last Price | 396.65 |
Change Percentage | -0.67% |
Open | 398.31 |
Previous Close | 399.32 |
Market Cap ( Millions) | 91992 |
Volume | 691454 |
Year High | 567.26 |
Year Low | 362.21 |
M A 50 | 388.51 |
M A 200 | 483.61 |
Financial Ratios
FCF Yield | 0.95% |
Dividend Yield | 1.64% |
ROE | 14.24% |
Debt / Equity | 4.87% |
Net Debt / EBIDTA | -14.34% |
Price To Book | 2.24 |
Price Earnings Ratio | 15.47 |
Price To FCF | 105.6 |
Price To sales | 0.52 |
EV / EBITDA | 1.96 |
News
- Jan -30 - 5 Stocks With Above-Market Yields Just Raised Payments Further
- Jan -29 - Billionaire Investor Sold These 5 Stocks And Loading Up On These Companies Instead
- Jan -27 - Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
- Jan -23 - Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums
- Jan -23 - Elevance Health, Inc. (ELV) Q4 2024 Earnings Call Transcript
- Jan -23 - Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
- Jan -23 - Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say
- Jan -23 - Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
- Jan -23 - Elevance Health (ELV) Q4 Earnings and Revenues Beat Estimates
- Jan -23 - Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
- Jan -23 - Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive.
- Jan -23 - Elevance Health earnings boost health-insurance stocks after upbeat outlook
- Jan -23 - Elevance beats quarterly profit estimates on lower-than-expected medical costs
- Jan -23 - Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
- Jan -21 - Mark Farrah Associates Delves into Acquisition Impacts Utilizing New Tools
- Jan -20 - Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
- Jan -17 - Unveiling Elevance Health (ELV) Q4 Outlook: Wall Street Estimates for Key Metrics
- Jan -09 - Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
- Jan -03 - My Top 15 High Growth Dividend Stocks For January 2025
- Dec -26 - Elevance Health Is An Undervalued Healthcare Juggernaut
Business Breakdown
Expected Mid-Term Growth
Segment nΒ°1 -> Health Benefits
Expected Growth : 6.5 %
What the company do ?
Elevance Health Inc. offers various health benefits, including medical, dental, vision, and pharmacy coverage, as well as wellness programs and disease management services.
Why we expect these perspectives ?
Elevance Health Inc.'s 6.5% growth is driven by increasing demand for health benefits, expansion into new markets, and strategic acquisitions. Additionally, the company's focus on digital transformation, cost savings initiatives, and growing government contracts also contribute to its growth. Furthermore, the rising need for affordable healthcare and the aging population are tailwinds for the company's health benefits segment.
Segment nΒ°2 -> CarelonRx
Expected Growth : 6.8 %
What the company do ?
CarelonRx is a pharmacy benefit management service from Elevance Health Inc., offering customized pharmacy solutions to improve health outcomes and reduce costs.
Why we expect these perspectives ?
CarelonRx's 6.8% growth is driven by increasing adoption of value-based care, expansion of Medicare Advantage and Medicaid programs, and growing demand for pharmacy benefit management services. Additionally, Elevance Health's strategic investments in digital health and analytics capabilities, as well as its strong relationships with healthcare providers, contribute to the segment's growth.
Segment nΒ°3 -> Eliminations
Expected Growth : 0.0 %
What the company do ?
Eliminations from Elevance Health Inc. refer to the removal of redundant or duplicate costs, revenues, or expenses between subsidiaries, resulting in a more accurate financial representation.
Why we expect these perspectives ?
Elevance Health Inc.'s elimination growth rate of 0.0% is driven by stagnant market demand, intense competition, and lack of innovation in the healthcare services sector. Additionally, the company's inability to reduce costs and improve operational efficiency has hindered its growth potential.
Segment nΒ°4 -> Carelon Services
Expected Growth : 7.2 %
What the company do ?
Carelon Services from Elevance Health Inc. provides healthcare management services, including care coordination, benefits management, and population health management, to improve healthcare outcomes and reduce costs.
Why we expect these perspectives ?
Carelon Services' 7.2% growth is driven by increasing demand for value-based care, expansion of Medicare Advantage and Medicaid programs, and strategic partnerships. Additionally, Elevance Health's investments in digital health and analytics capabilities, as well as its focus on population health management, are contributing to the segment's growth.
Segment nΒ°5 -> Reconciling Items
Expected Growth : 0.0 %
What the company do ?
Reconciling Items from Elevance Health Inc. refers to the process of identifying and resolving discrepancies between expected and actual financial transactions, ensuring accurate financial reporting and compliance.
Why we expect these perspectives ?
Elevance Health Inc.'s stagnant growth is attributed to intense competition in the healthcare industry, high operating expenses, and lack of innovation in their product offerings. Additionally, the company's failure to adapt to changing regulatory requirements and increasing customer expectations have hindered their ability to drive growth.
Segment nΒ°6 -> Corporate and Other
Expected Growth : 5.8 %
What the company do ?
Corporate and Other from Elevance Health Inc. refers to the unallocated corporate expenses, investments, and other non-operating items not attributed to its health insurance business segments.
Why we expect these perspectives ?
Elevance Health Inc.'s Corporate and Other segment growth of 5.8% is driven by increased investments in digital health initiatives, expansion of government programs, and strategic acquisitions. Additionally, cost savings from operational efficiencies and favorable tax rates also contribute to the segment's growth.
Elevance Health Inc. Products
Product Range | What is it ? |
---|---|
Anthem Medicare Advantage | Medicare Advantage plans that offer additional benefits and lower out-of-pocket costs |
Anthem Medicaid | Government-sponsored health insurance for low-income individuals and families |
Anthem Individual and Family Plans | Health insurance plans for individuals and families who don't have employer-sponsored coverage |
Anthem Group Insurance | Employer-sponsored health insurance plans for businesses of all sizes |
Elevance Health Pharmacy Benefits | Pharmacy benefits management services that help reduce prescription drug costs |
Elevance Health Care Management | Care management services that help improve health outcomes and reduce costs |
Elevance Health Data and Analytics | Data and analytics services that help improve health outcomes and reduce costs |
Elevance Health Inc.'s Porter Forces
Threat Of Substitutes
The threat of substitutes for Elevance Health Inc. is medium due to the presence of alternative healthcare services and products. However, the company's diversified portfolio and strong brand recognition mitigate this threat.
Bargaining Power Of Customers
The bargaining power of customers is low for Elevance Health Inc. due to the company's strong market position and the lack of buyer concentration in the healthcare industry.
Bargaining Power Of Suppliers
The bargaining power of suppliers is medium for Elevance Health Inc. due to the presence of multiple suppliers and the company's ability to negotiate prices. However, the company's dependence on certain suppliers for critical components may limit its bargaining power.
Threat Of New Entrants
The threat of new entrants is low for Elevance Health Inc. due to the high barriers to entry in the healthcare industry, including regulatory hurdles and the need for significant capital investments.
Intensity Of Rivalry
The intensity of rivalry is high for Elevance Health Inc. due to the presence of several established players in the healthcare industry, leading to intense competition for market share and customers.
Capital Structure
Value | |
---|---|
Debt Weight | 38.99% |
Debt Cost | 5.28% |
Equity Weight | 61.01% |
Equity Cost | 7.90% |
WACC | 6.88% |
Leverage | 63.91% |
Elevance Health Inc. : Quality Control
Elevance Health Inc. passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
Company | Rational |
---|---|
UNH | UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment β¦ |
CVS | CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer β¦ |
HUM | Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The β¦ |
CNC | Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage β¦ |
MCK | McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment β¦ |